1. The strange case of TGN1412

   • L. Farzaneh
   • N. Kasahara
   • F. Farzaneh

   Editorial 17 June 2006 Pages: 129 - 134

   

2. Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine

   • Matthew T. Hueman
   • Alexander Stojadinovic
   • George E. Peoples

   Original Article 17 June 2006 Pages: 135 - 146

   

3. Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody

   • Yunfeng Zhao
   • Michael Russ
   • Sybille Muller

   Original Article 03 August 2006 Pages: 147 - 154

   

4. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

   • D. Ritchie
   • L. Mileshkin
   • H. M. Prince

   Original Article 30 May 2006 Pages: 155 - 163

   

5. Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen

   • Sumia Ali
   • Kate Mulryan
   • Peter L. Stern

   Original Article 07 June 2006 Pages: 165 - 180

   

6. Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin

   • Hai Lian
   • Ningyi Jin
   • Ping Li

   Original Article 10 June 2006 Pages: 181 - 192

   

7. Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells

   • Simona Vertuani
   • Eugenia Dubrovska
   • Jelena Levitskaya

   Original Article 03 June 2006 Pages: 193 - 204

   

8. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10

   • Mingzhong Zheng
   • Dora Bocangel
   • Sunil Chada

   Original Article 19 May 2006 Pages: 205 - 215

   

9. Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice

   • Arthur Machlenkin
   • Ronit Azriel-Rosenfeld
   • Lea Eisenbach

   Original Article 01 June 2006 Pages: 217 - 226

   

10. Immune selective pressure and HLA class I antigen defects in malignant lesions

    • Chien-Chung Chang
    • Soldano Ferrone

    Original Article 17 June 2006 Pages: 227 - 236

    

11. Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model

    • Mariano F. Zacarías Fluck
    • María J. Rico
    • O. Graciela Scharovsky

    Original Article 30 May 2006 Pages: 237 - 248

    

12. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

    • Alfred Zippelius
    • Asma Gati
    • Dirk Jaeger

    Original Article 23 May 2006 Pages: 249 - 258

    

13. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules

    • Tomoko So
    • Takeshi Hanagiri
    • Pierre G. Coulie

    Original Article 07 June 2006 Pages: 259 - 269